Author:
Feng Bao-Jie,Li Tian-Hua,Li Yue-Hong,Feng Jing-Xuan,Zhang Jun,Ma Jun-Ying,Wang Yan-Wei,Lu Su-Shuang
Abstract
Abstract
Background
Ovarian neuroendocrine carcinoma (O-NEC) is a relatively uncommon neoplasm, and the current knowledge regarding its diagnosis and management is limited. In this series, our objective was to provide an overview of the clinicopathological characteristics of the disease by analyzing clinical case data to establish a theoretical foundation for the diagnosis and management of O-NEC.
Case presentation
We included three patients in the present case series, all of whom were diagnosed with primary O-NEC based on pathomorphological observation and immunohistochemistry. Patient 1 was a 62-year-old patient diagnosed with small cell carcinoma (SCC) of the pulmonary type. Post-surgery, the patient was diagnosed with stage II SCC of the ovary and underwent standardized chemotherapy; however, imaging examinations conducted at the 16-month follow-up revealed the existence of lymph node metastasis. Unfortunately, she passed away 21 months after the surgery. The other two patients were diagnosed with carcinoid tumors, one at age 39 and the other at age 71. Post-surgery, patient 2 was diagnosed with a carcinoid in the left ovary, whereas patient 3 was diagnosed with a carcinoid in her right ovary based on clinical evaluation. Neither of the cases received adjuvant therapy following surgery; however, they have both survived for 9 and 10 years, respectively, as of date.
Conclusion
Primary O-NECs are rare and of diverse histological types, each of which has its own unique biological features and prognosis. SCC is a neoplasm characterized by high malignancy and a poor prognosis, whereas carcinoid tumors are of lesser malignancy and have a more favorable prognosis.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference16 articles.
1. Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL. Overview of the 2022 WHO classification of neuroendocrine Neoplasms. Endocr Pathol. 2022;33:115–54.
2. Taraszewski R, Rosman PM, Knight CA. Cloney DJ.Small cell carcinoma of the ovary. Gynecol Oncol. 1991;41(2):149–51.
3. Cai J, Hua P, Hu ZM, Lin WY, Lai N. Primary small cell neuroendocrine carcinoma of ovary: a case report. J Canc Control Treat. 2014;(5):256–8.
4. Guo HN, Li JJ, Zhang L, Ren X, Sun YX. A case of ovarian neuroendocrine Tumor and literature review. Chin J Clin Obstet Gynecol. 2014;15(3):278–9.
5. Niu H, Zhao LP, Liu Y, Wu SY, Xu TM. Clear cell carcinoma of ovary with intestinal borderline mucinous Tumor and small cell neuroendocrine carcinoma: a case report and literature review. Chin J Lab Diagnosis. 2016;(1):148–9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献